Cancer stem cell-based models of colorectal cancer reveal molecular determinants of therapy resistance

Sara Vitale, Ruggero De Maria Marchiano, Maria Laura De Angelis, Giorgio Russo, Federica Francescangeli, Marco Tartaglia, Ann Zeuner, Eleonora Policicchio, Alessandro Bruselles, Michele Signore, Gabriele De Luca, Emanuela Pilozzi, Alessandra Boe, Giorgio Stassi, Lucia Ricci-Vitiani, Carla Azzurra Amoreo, Alfredo Pagliuca, Marta Baiocchi

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

29 Citazioni (Scopus)

Abstract

Colorectal cancer (CRC) therapy mainly relies on the use of conventional chemotherapeutic drugs combined, in a subset of patients, with epidermal growth factor receptor [EGFR]-targeting agents. Although CRC is considered a prototype of a cancer stem cell (CSC)-driven tumor, the effects of both conventional and targeted therapies on the CSC compartment are largely unknown. We have optimized a protocol for colorectal CSC isolation that allowed us to obtain CSC-enriched cultures from primary tumor specimens, with high efficiency. CSC isolation was followed by in vitro and in vivo validation, genetic characterization, and drug sensitivity analysis, thus generating panels of CSC lines with defined patterns of genetic mutations and therapy sensitivity. Colorectal CSC lines were polyclonal and maintained intratumor heterogeneity in terms of somatically acquired mutations and differentiation state. Such CSC-enriched cultures were used to investigate the effects of both conventional and targeted therapies on the CSC compartment in vivo and to generate a proteomic picture of signaling pathways implicated in sensitivity/resistance to anti-EGFR agents.Wepropose CSC lines as a sound preclinical framework to test the effects of therapies in vitro and in vivo and to identify novel determinants of therapy resistance.
Lingua originaleEnglish
pagine (da-a)511-523
Numero di pagine13
RivistaStem cells translational medicine
Volume5
DOI
Stato di pubblicazionePubblicato - 2016

Keywords

  • Animals
  • Anti-EGFR therapy
  • Cancer stem cells
  • Cell Biology
  • Cells, Cultured
  • Cetuximab
  • Colorectal Neoplasms
  • Colorectal cancer
  • Developmental Biology
  • Drug Resistance, Neoplasm
  • Female
  • Gene Expression Profiling
  • Humans
  • Mice, Inbred NOD
  • Mice, SCID
  • Mice, Transgenic
  • Microarray Analysis
  • Models, Biological
  • Neoplastic Stem Cells
  • Protein Kinase Inhibitors
  • Proteomic arrays
  • Proteomics
  • Signal Transduction

Fingerprint Entra nei temi di ricerca di 'Cancer stem cell-based models of colorectal cancer reveal molecular determinants of therapy resistance'. Insieme formano una fingerprint unica.

Cita questo